Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solcitinib (GLPG-0778) (GSK2586184, GLPG0778) is a JAK1 inhibitor. Solcitinib may be potentially used for the treatment of psoriasis, ulcerative colitis, and systemic lupus erythematosus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 153.00 | |
50 mg | In stock | $ 198.00 | |
100 mg | In stock | $ 328.00 | |
200 mg | In stock | $ 528.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | Solcitinib (GLPG-0778) (GSK2586184, GLPG0778) is a JAK1 inhibitor. Solcitinib may be potentially used for the treatment of psoriasis, ulcerative colitis, and systemic lupus erythematosus. |
Targets&IC50 | JAK1:8-9 nM |
Kinase Assay | In vitro HotSpotSM kinase profiling of 289 kinases is performed. The assay is conducted in the presence of 10 μM [33P]-ATP, using brigatinib concentrations ranging from 0.05 nM to 1 μM. |
Synonyms | GLPG-0778, GSK-2586184 |
Molecular Weight | 389.45 |
Formula | C22H23N5O2 |
CAS No. | 1206163-45-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL(51.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Solcitinib 1206163-45-2 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK GLPG0778 Janus kinase GLPG 0778 Inhibitor GSK 2586184 inhibit GLPG-0778 GSK2586184 GSK-2586184 inhibitor